Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE ( © Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 February 2020

Abstract and Keywords

This article discusses the politics of the regulation of biotechnology in the life sciences and health care in Canada. Biotechnology is one of the four areas of science and technology that is identified by the Canadian government as a priority. The first section of this article discusses the two constitutive elements of regulatory political cultures in relation to novel technologies: ideas and institutional practices on how collective knowledge of the risk and benefits of novel technology is produced and validated; and the formal and informal methods of ensuring accountability and legitimacy in the decision making with respect to technology. The second section explores Canada's regulatory political culture and politics. It discusses the Canadian political culture of deference to science and technology. The third and last section examines the politics of the regulation of biotechnology in the nation as illustrated by genetically modified crops and the assisted productive technologies.

Keywords: politics, regulation of biotechnology, biotechnology, science and technology, regulatory political cultures, culture of deference, politics of regulation

Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.